A Safety and Activity Study of NS2 in Subjects With Allergic Conjunctivitis
Trial details
- Registry ID
- NCT02578914
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Safety and Activity Study of NS2 in Subjects With Allergic ConjunctivitisNCT02578914 | ALDX | Phase 2 | Completed | 2015-12Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |